A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants

Rotavirus is the most common cause of moderate-to-severe infant diarrhoea in developing countries, resulting in enormous morbidity, mortality, and economic burden. A bovine-human reassortant pentavalent rotavirus vaccine (BRV-PV) targeting the globally most common strains was developed in India and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccine
Main Authors: Kulkarni, Prasad S., Desai, Sajjad, Tewari, Tushar, Kawade, Anand, Goyal, Nidhi, Garg, Bishan Swarup, Kumar, Dinesh, Kanungo, Suman, Kamat, Veena, Kang, Gagandeep, Bavdekar, Ashish, Babji, Sudhir, Juvekar, Sanjay, Manna, Byomkesh, Dutta, Shanta, Angurana, Rama, Dewan, Deepika, Dharmadhikari, Abhijeet, Zade, Jagdish K., Dhere, Rajeev M., Fix, Alan, Power, Maureen, Uprety, Vidyasagar, Parulekar, Varsha, Cho, Iksung, Chandola, Temsunaro R., Kedia, Vikash K., Raut, Abhishek, Flores, Jorge
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Science 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5651219/
https://ncbi.nlm.nih.gov/pubmed/28967523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2017.09.014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados